Articles > Popular publications > PR Newswire press releases > April-June 2008 > Thursday, May 15

Article: Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies.

Article from:
PR Newswire
Article date:
May 15, 2008
Copyright

COLLEGEVILLE, Pa., May 15 /PRNewswire/ -- Wyeth Pharmaceuticals, a division of Wyeth , announced today that PRISTIQ(TM) (desvenlafaxine), a new serotonin-norepinephrine reuptake inhibitor (SNRI) approved to treat adult patients with major depressive disorder (MDD), is now available in U.S. retail pharmacies nationwide. The recommended dose of PRISTIQ is 50 milligrams (mg) once daily. The Company begins full-scale selling and educational efforts regarding PRISTIQ for physicians this week.

"We are proud to make PRISTIQ available as a new treatment option for the millions of American adults who struggle with depression," comments Philip Ninan, M.D., Vice ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Wyeth Receives Approvable Letter From FDA for Pristiq ...
PR Newswire;  January 23, 2007 ;     700+ words ... ... Administration (FDA) for Pristiq(TM) (desvenlafaxine ... adult patients with major depressive disorder (MDD ... with our plans for Pristiq," says Joseph Mahady ... antidepressant in the world. Pristiq represents Wyeth ... and adolescents with major depressive disorder and other ...

Article: FDA Approves PRISTIQ(TM) for the Treatment of Adult ...
PR Newswire;  March 1, 2008 ;     700+ words ... ... FDA) has approved PRISTIQ(TM) (desvenlafaxine ... adult patients with major depressive disorder (MDD ... expects to begin shipping PRISTIQ to wholesalers beginning ... antidepressant in the world. PRISTIQ, also discovered and ... neuroscience. About Major Depressive Disorder ...

Article: New Phase 3 Data Showed PRISTIQ Significantly Reduced ...
PR Newswire;  December 12, 2007 ;     700+ words ... ... 50 mg/Day Dose for PRISTIQ for the Treatment of Major Depressive Disorder COLLEGEVILLE ... clinical studies of PRISTIQ(TM) (desvenlafaxine ... 50 mg/day dose of PRISTIQ for the treatment of major depressive disorder (MDD) experienced ...

Article: Wyeth's Pristiq extends relapse time in MDD.(major ...
Pharma Marketletter;  June 4, 2007 ;     700+ words ... ... norepinephrine reuptake inhibitor Pristiq (desvenlafaxine succinate ... extended time to relapse in major depressive disorder patients versus placebo ... that more patients who took Pristiq achieved remission, defined ... by 4% of patients who took Pristiq vs 8% of those on placebo ...

Article: Wyeth Receives Approvable Letter from FDA for PRISTIQ for ...
PR Newswire;  July 24, 2007 ;     700+ words ... ... associated with the use of PRISTIQ in this indication. The Agency ... committed to the development of PRISTIQ as a potential treatment for ... received an approvable letter for PRISTIQ for the treatment of Major Depressive Disorder (MDD), which did ...

Article: Desvenlafaxine Succinate Extended-Release Tablets ...
Internal Medicine Alert;  March 29, 2008 ;     700+ words ... ... Release Tablets (Pristiq™) By ... under the trade name Pristiq. Indications Desvenlafaxine ... for the treatment of major depressive disorder (MDD ... norepinephrine. Its efficacy in major depressive disorder was shown ... form. References 1. Pristiq Product Information ...

Article: Wyeth Sets Conference Call and Webcast to Provide Pristiq ...
PR Newswire;  July 31, 2007 ;     700+ words ... ... for registration of Pristiq(TM) (desvenlafaxine ... and the treatment of major depressive disorder. The conference ... our expectations for Pristiq are based on a preliminary ... vasomotor symptoms and major depressive disorder indications ... products (including Pristiq); government ...

Article: For Pristiq promo, Wyeth deploys a wind-up doll.(NEWS)
Medical Marketing & Media;  July 1, 2009 ;     700+ words ... ... global business manager for Pristiq, "the idea of winding yourself ... The use of the doll gives Pristiq a memorable visual "that we ... Approved for the treatment of major depressive disorder, Pristiq launched into the jam-packed ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives